The 14th Asia-Pacific Travel Health Conference is set to take place in Kathmandu from 18-21 September, bringing together 200 delegates from 27 countries to explore advances in travel medicine which have relevance for Nepal’s own tourism industry.
The biannual conference is the first in four years after its 13th iteration in New Zealand in 2020 was cancelled due to the Covid-19 pandemic. Previous conferences have been held in Bangkok and in Kathmandu in 2016.
Lessons for the travel industry from the Covid-19 pandemic will be prominent in the agenda of the conference in which experts from the International Society of Travel Medicine will also be taking part. Nearly 60 of the 200 participants are from Nepal.
"The careful practice of travel medicine can be an important sentinel for diseases,” says Buddha Basnyat, MD, Chair of the Oxford University Clinical Research Unit-Nepal, who is part of the Nepali delegation.
The 3-day event will kick off with a day-long Pre-Conference Seminar on Adventure and Wilderness Travel, as well as separate sessions on mental health strategies and military medicine before the main events next week.
“Travel medicine is very relevant to Nepal because it has always been a desirable tourism destination,” says Pratibha Pandey, MD, of CIWEC Hospital and Travel Medicine Center, which is a partner to the Asia-Pacific Travel Health Society.
She adds: “Outbreaks of diseases like dengue, issues of road and aviation safety, and economic hardships have had an impact on the number of travellers coming to Nepal, which will be reflected at the conference.”
Read also: Poor safety to hit Nepal tourism, Sonia Awale
Each day of the conference will include three plenary panels, followed by parallel symposia, communication sessions, and interactive workshops. The conference will highlight special groups, including the elderly, pregnant, and otherwise immuno-compromised travellers.
An ‘ABC’ workshop which will provide participants with the basics of setting up a clinic and explain pre-travel consultations. Other sessions include discussion about vaccines, including a plenary on the changing immunisation landscape, newer vaccine technologies, as well as a seminar on the Japanese Qdenga vaccine against dengue that has not yet been licensed for use in Nepal.

